| Position | Last | Day | Thesis | Chart | Beta | Spread Z | 1Y · levels | Next catalyst | In |
|---|---|---|---|---|---|---|---|---|---|
| $6.40 | -3.0% | 1.75 | -1.42 | Est. Q3 earningsNov 10 | 88d | ||||
ValuationMarket cap$5.6B P/B3.5× RevenuePre-commercial Last$6.40 SectorReal Estate / Infrastructure Intrinsic entry levelsBear$4.47 Base$7.26 Bull$15.00 Trading -12% versus base case A development-stage bet on Project Matador becoming a scarce, gigawatt-scale powered AI campus. Commercial agreements and funded delivery—not headline capacity—must validate it. | |||||||||
| $10.75 | -2.2% | 0.34 | -1.83 | Est. fiscal Q4 earningsNov 19 | 97d | ||||
ValuationFiscal Q3 sales growth4.2% Fiscal Q3 adjusted EBITDA$78.3M Adjusted gross margin27.7% Last$10.75 SectorConsumer Staples Market reference levels1Y low$7.90 Aug 12 close$10.85 1Y high$42.68 Trading -1% versus Aug 12 close Legacy Robinhood protein holding. The GLP-1 muscle-preservation theme does not currently provide a clean BRBR-specific public-equity expression; retain it transparently while brand-level volume, pricing, and margin evidence either creates a direct thesis or invalidates it. | |||||||||
| $24.78 | -1.2% | 1.03 | -0.14 | Est. Q3 earningsOct 28 | 75d | ||||
ValuationQ2 revenue$319.7M Q2 adjusted EBITDA$136.7M Net revenue retention108% Last$24.78 SectorHealth Care Market reference levels1Y low$17.31 Aug 13 close$25.08 1Y high$40.89 Trading -1% versus Aug 13 close Waystar is a healthcare-payment software compounder: subscription growth, 108% retention, and 43% adjusted EBITDA margin must keep converting provider complexity into recurring cash flow without acquisition or leverage drag. | |||||||||
| $87.80 | +0.1% | 1.68 | -2.31 | Est. Q3 earningsNov 5 | 83d | ||||
ValuationQ2 net sales$627.0M Q2 gross margin24.3% Total backlog$2.0B Last$87.80 SectorIndustrials Market reference levels52W low$71.77 Aug 13 close$87.67 52W high$148 Trading +0% versus Aug 13 close AAON is a data-center cooling and custom HVAC capacity-ramp position. Record BASX demand and a $2.0 billion backlog must convert into revenue, improving gross margin, and cash generation faster than Memphis overhead, outsourcing, and working-capital needs consume the upside. | |||||||||
| Thesis | Last | Day | Thesis | Chart | Beta | Spread Z | 1Y | Next catalyst | In |
|---|---|---|---|---|---|---|---|---|---|
| $21.61 | -0.8% | 0.92 | -1.78 | Est. Q3 earningsNov 3 | 81d | ||||
ValuationQ2 revenue$2.8B Q2 adjusted EBITDA$407M Q2 free cash flow-$153M Last$21.61 SectorSee full thesis Market reference levels1Y low$19.82 Aug 12 close$22.60 1Y high$31.04 Trading -4% versus Aug 12 close | |||||||||